Studies are conducted to define the mechanisms involved in tumor growth and metastasis and to develop new animal models of human cancers. We have found that a basement membrane extract (Matrigel) when premixed with human tumor cells (which do not grow well in mice) promotes their incidence and growth. Very low cell numbers can be used. We have been able to culture new highly differentiated human tumor cell lines from the tumors grown in mice including certain colon cell lines and a Nelson's pituitary tumor cell line. Laminin, a major basement membrane component, has been found to promote the malignant phenotype. Various biologically active laminin-derived synthetic peptides have been identified. YIGSR from the B1 chain blocks lung colonization, reduces tumor growth, and inhibits angiogenesis. Using multiple cycles of YIGSR adhesion, YIGSR adherent melanoma cells were derived and formed more tumors in lung colony assays and larger tumors in the subcutaneous model than the parent cells. The YIGSR non-adherent cells formed few tumors. Selection for adhesion to laminin was carried out with a human colon cancer and the adherent cells were found to be highly malignant when injected intracecally with Matrigel. These cells grew well and metastasized to the liver and surrounding tissues. This progression models the pathological process in humans. Another laminin-derived peptide containing SIKVAV from the A chain has been found to increase tumor growth, lung colonization, and angiogenesis as well as collagenase IV activity and plasminogen activation. This peptide was found to promote angiogenesis in one in vivo model by increasing the recruitment of neutrophils. Using this information and the newly developed models of human tumors, the development of new therapeutic strategies for cancer should be facilitated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000482-06
Application #
3753550
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
National Institute of Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Campo McKnight, Dianalee A; Sosnoski, Donna M; Koblinski, Jennifer E et al. (2006) Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem 97:288-302
Koblinski, Jennifer E; Kaplan-Singer, Benjamin R; VanOsdol, Sherilyn J et al. (2005) Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 65:7370-7
Huh, Jung-Im; Calvo, Alfonso; Stafford, Jeffrey et al. (2005) Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene 24:790-800
Lugassy, Claire; Kleinman, Hynda K; Engbring, Jean A et al. (2004) Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol 164:1191-8
Munshi, Hidayatullah G; Wu, Yi I; Mukhopadhyay, Subhendu et al. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 279:39042-50
Hibino, Suguru; Shibuya, Masahiko; Engbring, Jean A et al. (2004) Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64:4810-6
Bos, T J; Cohn, S L; Kleinman, H K et al. (2004) International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. Matrix Biol 23:63-9
Elkin, Michael; Orgel, Adam; Kleinman, Hynda K (2004) An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 96:875-8
Elkin, Michael; Cohen, Irit; Zcharia, Eyal et al. (2003) Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 63:8821-6
Cha, Hee-Jae; Jeong, Moon-Jin; Kleinman, Hynda K (2003) Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95:1674-80

Showing the most recent 10 out of 12 publications